Enfermedades de la placa neuromuscular


Autoria(s): Pedroza Rojas, Alvaro Alexander; Rodriguez Quintana, Jesús Hernán
Contribuinte(s)

Rodriguez Quintana, Jesús Hernán

Data(s)

17/07/2013

Resumo

En este capítulo se describen las enfermedades de la placa neuromuscular, su epidemiología, hallazgos clínicos, métodos diagnósticos y tratamiento de cada una de ellas

In this chapter we describe the neuromuscular transmission disorders, the epidemiology, clinical features, diagnosis and treatment

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/4611

Idioma(s)

spa

Publicador

Facultad de Medicina

Direitos

info:eu-repo/semantics/openAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

1. Meriggioli, M; Myasthenia Gravis: Immunopathogenesis, Diagnosis and Management; Continuum lifelong in learning Neurology, 2009, 15(1) 36 – 62.

2. Skeie, G.O et al; Guidelines for the Treatment of Autoinmune Neuromuscular Transmission Disorders; European Journal of Neurology; 2006; 13. 691 – 699.

3. Tormochlen, L; Pazcussi, R; Thymomma, Myasthenia Gravis and Other Paraneoplatsic Syndromes; Hematology – Oncology Clinics of North America 22; 2008; 509 – 526.

4. Vernino, S; Paraneoplastic Disorders Affecting the Neuromuscular Junction or Anterior Horn Cell; Continuum Lifelong in Learning Neurology; 2009; (15)1, 132 – 146.

5. Eggenberger, E; Neuromuscular Junction and Mechanical Causes of Dyplopia; Continuum Lifelong in Learning Neurology; 2009; 188 – 199.

6. Rowin, J; Approach to the Patient with Suspected Myasthenia Gravis or ALS: A Clinical Guide; Continuum Lifelong in Learning Neurology; 2009; 15(1), 13 – 34.

7. Sanders, D; Howard, J; Disorders of Neuromuscular Transmission; Bradley, W, Neurology in Clinical Practice, Chapter 82, 2011.

8. Faye, Y; Chiu – Tan; Electromyographic Approach to Neuromuscular Junction Disorders Repetitive Nerve Stimulation and Single Fiber Electromyography; Physical Medical and Rehabilitation Clinics of North America; 14 (2003); 387 – 401.

9. Juel, V; Evaluation of Neuromuscular Junction Disorders in the Electromyography Laboratory; Neurologic Clinics of North America; 30 (2012); 621 – 639.

10. Rowin, J; Autoimmune Basis of Myasthenia Gravis; Continuum Lifelong in Learning Neurology; 25(2002); 11 – 16.

11. Blalock, A et al; Treatment of Myasthenia Gravis; Continuum Lifelong in Learning Neurology; 25(2002); 29 – 58.

12. Rezania, K; Neuromuscular Disorders and Acute Respiratory Failure: Diagnosis and Management; Neurologic Clinics of North America; 30 (2012); 161 – 185.

13. Harper, M; Congenital Myasthenic Syndrommes; Continuum Lifelong in Learning Neurology; 2009; 15(1); 63 – 82.

14. Benatar, M; et al; Evidence Report: The Medical Treatment of Ocular Myasthenia (an evidence based review); Neurology; 2007; 68:2144 – 2149.

Palavras-Chave #BOTULISMO #ENFERMEDADES NEUROMUSCULARES #MIASTENIA GRAVIS #NEUROFISIOLOGÍA - INVESTIGACIONES #SÍNDROME DE LAMBERT-EATON #neuromuscular transmission disorders #miastenia gravis #Lambert Eaton syndromme #Botulism
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion